CF-012

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCF-012
Drug Alias NameCF-012
ClassificationSmall molecules
Mechanisms of ActionETS translocation variant 6 inhibitors
TargetsETS translocation variant 6
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC-Further
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteC-FurtherMass General Brigham Inc +[4] 
Inactive CompaniesN/A
Active IndicationsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A